$522 Million is the total value of SABBY MANAGEMENT, LLC's 106 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | PARETEUM CORPput | $0 | – | -299 | -100.0% | -0.00% | – | |
| Exit | LIPOCINE INC NEWput | $0 | – | -150 | -100.0% | -0.00% | – | |
| BKYI | Exit | BIO KEY INTL INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| Exit | ZOMEDICA PHARMACEUTICALS | $0 | – | -470,548 | -100.0% | -0.01% | – | |
| Exit | NABRIVA THERAPEUTICS PLCput | $0 | – | -958 | -100.0% | -0.01% | – | |
| BNTC | Exit | BENITEC BIOPHARMA INC | $0 | – | -11,863 | -100.0% | -0.01% | – |
| CTXR | Exit | CITIUS PHARMACEUTICALS | $0 | – | -88,711 | -100.0% | -0.01% | – |
| MDGSW | Exit | MEDIGUS LTD*w | $0 | – | -544,940 | -100.0% | -0.01% | – |
| Exit | LM FUNDING AMERICA INC | $0 | – | -147,304 | -100.0% | -0.01% | – | |
| Exit | BAUDAX BIO INCput | $0 | – | -410 | -100.0% | -0.02% | – | |
| Exit | CURIS INCcall | $0 | – | -1,131 | -100.0% | -0.02% | – | |
| Exit | LIPOCINE INC NEWcall | $0 | – | -941 | -100.0% | -0.02% | – | |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -268,109 | -100.0% | -0.02% | – | |
| Exit | ACTINIUM PHARMACEUTICALSput | $0 | – | -164 | -100.0% | -0.02% | – | |
| CLBS | Exit | CALADRIUS BIOSCIENCES | $0 | – | -96,001 | -100.0% | -0.03% | – |
| Exit | CATABASIS PHARMScall | $0 | – | -277 | -100.0% | -0.03% | – | |
| HEPA | Exit | HEPION PHARMACEUTICALS | $0 | – | -57,309 | -100.0% | -0.03% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -13,800 | -100.0% | -0.03% | – |
| SNCA | Exit | SENECA BIOPHARMA INC | $0 | – | -393,411 | -100.0% | -0.03% | – |
| Exit | GENOCEA BIOSCIENCES INCcall | $0 | – | -1,032 | -100.0% | -0.04% | – | |
| MKGI | Exit | MONAKER GROUP INC | $0 | – | -134,585 | -100.0% | -0.04% | – |
| SCPH | Exit | SCPHARMACEUTICALS INC | $0 | – | -42,407 | -100.0% | -0.05% | – |
| USEG | Exit | U S ENERGY CORP WY | $0 | – | -66,504 | -100.0% | -0.05% | – |
| Exit | CYTOKINETICS INCcall | $0 | – | -157 | -100.0% | -0.05% | – | |
| PAVMZ | Exit | PAVMED INC*w | $0 | – | -436,973 | -100.0% | -0.05% | – |
| XLV | Exit | SELECT SECTOR SPDR TRetf | $0 | – | -4,000 | -100.0% | -0.06% | – |
| ADTX | Exit | ADITX THERAPEUTICS INC | $0 | – | -224,971 | -100.0% | -0.07% | – |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS | $0 | – | -125,578 | -100.0% | -0.07% | – |
| Exit | ODONATE THERAPEUTICS INCput | $0 | – | -354 | -100.0% | -0.07% | – | |
| Exit | CATABASIS PHARMSput | $0 | – | -891 | -100.0% | -0.08% | – | |
| Exit | SAREPTA THERAPEUTICcall | $0 | – | -44 | -100.0% | -0.09% | – | |
| LPCN | Exit | LIPOCINE INC NEW | $0 | – | -443,469 | -100.0% | -0.09% | – |
| PSTI | Exit | PLURISTEM THERAPEUTICS | $0 | – | -59,730 | -100.0% | -0.09% | – |
| BBI | Exit | BRICKELL BIOTECH INC | $0 | – | -721,887 | -100.0% | -0.10% | – |
| Exit | AKERS BIOSCIENCES INC | $0 | – | -299,913 | -100.0% | -0.10% | – | |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -312,666 | -100.0% | -0.11% | – |
| TTNP | Exit | TITAN PHARMACEUTICALS | $0 | – | -4,856,723 | -100.0% | -0.12% | – |
| PDSB | Exit | PDS BIOTECHNOLOGY CORP | $0 | – | -419,836 | -100.0% | -0.15% | – |
| Exit | ALTIMMUNE INCput | $0 | – | -761 | -100.0% | -0.15% | – | |
| Exit | AURINIA PHARMACEUTICALScall | $0 | – | -704 | -100.0% | -0.16% | – | |
| Exit | SAREPTA THERAPEUTICput | $0 | – | -76 | -100.0% | -0.16% | – | |
| OLB | Exit | OLB GROUP INC | $0 | – | -311,010 | -100.0% | -0.17% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -29,654 | -100.0% | -0.18% | – |
| CRIS | Exit | CURIS INC | $0 | – | -1,179,600 | -100.0% | -0.21% | – |
| IBB | Exit | ISHARES NASDAQ BIOTECHetf | $0 | – | -11,372 | -100.0% | -0.23% | – |
| CNTG | Exit | CENTOGENE N V | $0 | – | -182,275 | -100.0% | -0.26% | – |
| EYEN | Exit | EYENOVIA INC | $0 | – | -608,720 | -100.0% | -0.28% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -880,400 | -100.0% | -0.30% | – |
| Exit | CELLDEX THERAPEUTICcall | $0 | – | -1,392 | -100.0% | -0.31% | – | |
| NVCN | Exit | NEOVASC INC | $0 | – | -1,009,406 | -100.0% | -0.32% | – |
| SHIP | Exit | SEANERGY MARITIME | $0 | – | -5,349,284 | -100.0% | -0.36% | – |
| COCP | Exit | COCRYSTAL PHARMA INC | $0 | – | -2,667,293 | -100.0% | -0.37% | – |
| VXX | Exit | BARCLAYS BANK PLCetf | $0 | – | -100,000 | -100.0% | -0.37% | – |
| CKPT | Exit | CHECKPOINT THERAPEUTICS | $0 | – | -931,240 | -100.0% | -0.37% | – |
| Exit | ISHARES NASDAQ BIOTECHcall | $0 | – | -189 | -100.0% | -0.38% | – | |
| Exit | TRILLIUM THERAPEUTICS INCcall | $0 | – | -1,860 | -100.0% | -0.40% | – | |
| CIDM | Exit | CINEDIGM CORP | $0 | – | -4,875,949 | -100.0% | -0.41% | – |
| Exit | ASTRAZENECA PLCcall | $0 | – | -521 | -100.0% | -0.43% | – | |
| Exit | SPI ENERGY CO LTD | $0 | – | -425,762 | -100.0% | -0.46% | – | |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -99,921 | -100.0% | -0.62% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -50,000 | -100.0% | -0.64% | – |
| Exit | FIBROGEN INCput | $0 | – | -1,418 | -100.0% | -0.87% | – | |
| Exit | PLURISTEM THERAPEUTICSput | $0 | – | -5,984 | -100.0% | -0.94% | – | |
| Exit | PFIZER INCcall | $0 | – | -1,817 | -100.0% | -1.00% | – | |
| SRNE | Exit | SORRENTO THERAPEUTICS | $0 | – | -606,298 | -100.0% | -1.01% | – |
| Exit | SELECT SECTOR SPDR TRcall | $0 | – | -834 | -100.0% | -1.31% | – | |
| Exit | ISHARES NASDAQ BIOTECHput | $0 | – | -923 | -100.0% | -1.87% | – | |
| Exit | TESLA INCput | $0 | – | -435 | -100.0% | -3.20% | – | |
| Exit | SPDR S&P 500call | $0 | – | -867 | -100.0% | -4.34% | – | |
| Exit | TESLA INCcall | $0 | – | -850 | -100.0% | -5.44% | – | |
| Exit | SELECT SECTOR SPDR TRput | $0 | – | -4,634 | -100.0% | -7.30% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.